Publicaciones en las que colabora con Gorka Gereñu Lopetegi (8)

2017

  1. Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1863, Núm. 4, pp. 991-1001

2016

  1. Down-regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease

    Hippocampus, Vol. 26, Núm. 10, pp. 1303-1312

2013

  1. EFECTOS DE LA ESTIMULACIÓN COGNITIVA EN LA ENFERMEDAD DE ALZHEIMER: IMPLICACIÓN DE BDNF

    EFECTOS DE LA ESTIMULACIÓN COGNITIVA EN LA ENFERMEDAD DE ALZHEIMER: IMPLICACIÓN DE BDNF

  2. Early cognitive stimulation compensates for memory and pathological changes in Tg2576 mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1832, Núm. 6, pp. 837-847

  3. Mineralocorticoid Receptor Activation Induces Insulin Resistance Through c-Jun N-terminal kinases in Response to Chronic Corticosterone: Cognitive Implications

    Journal of Neuroendocrinology, Vol. 25, Núm. 4, pp. 350-356

  4. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice

    International Journal of Neuropsychopharmacology

2012

  1. Cholinergic denervation exacerbates amyloid pathology and induces hippocampal atrophy in Tg2576 mice

    Neurobiology of Disease, Vol. 48, Núm. 3, pp. 439-446

  2. Mechanisms involved in BACE upregulation associated to stress

    Current Alzheimer Research, Vol. 9, Núm. 7, pp. 822-829